Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. SCHLX: which is better?

Bottom line

PRHSX vs SCHLX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 72% by weight.

But PRHSX is far broader, holding 279 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.

PRHSX is cheaper at 0.83% vs 1.06% — a difference of $23 a year per $10,000 invested.

Updated Nov 19, 2026

PRHSX vs SCHLX side by side

PRHSXSCHLX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceDWS (Xtrackers)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%1.06%
Annual cost per $10k$83$106
10-yr cost on $10k (prospectus)$1,025$1,294
Max front load—0%
12b-1 fee—0%
1-yr return+17.7%—
5-yr return (annualized)+4.2%—
10-yr return (annualized)+9.1%—
Best quarter+23.5%—
Worst quarter−15.8%—
Net assets (fund)$11.9B$231.8M
Number of holdings27965
Portfolio turnover62%2%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

15 of PRHSX's top 25 holdings also appear in SCHLX's top 25.

Shared top holdings
HoldingPRHSXSCHLX
Eli Lilly & Co14.28%13.85%
Johnson & Johnson6.63%6.19%
Unitedhealth Group Inc5.99%5.73%
Abbvie Inc5.10%4.90%
Merck & Co. Inc.4.01%4.85%
Gilead Sciences Inc2.82%2.78%
Thermo Fisher Scientific Inc2.52%3.46%
Vertex Pharmaceuticals Inc2.28%2.45%
Bristol-myers Squibb Co2.11%1.50%
Abbott Laboratories1.89%2.39%
Intuitive Surgical Inc1.87%2.69%
Amgen Inc1.82%2.88%
Stryker Corp1.78%2.61%
Danaher Corp1.43%2.13%
Cardinal Health Inc1.03%1.34%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

SCHLX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

FAQ

What is the difference between PRHSX and SCHLX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 72% by weight. But PRHSX is far broader, holding 279 positions to 65 for SCHLX, so beyond the top names it adds exposure SCHLX doesn't have.
Which is cheaper, PRHSX or SCHLX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and SCHLX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.